This indicates that beyond the clinical dimension and nodal stage of the tumor, various molecular-level factors like p 53 mutations, angiogenesis-related factors, cyclin D1, cytokeratin 8/18, epidermal growth factor and transforming growth factor beta are also involved in determining the prognosis and clinical outcome of the disease [21]. The gene discussed is EGF; the disease is neoplasm.